TONIX PHARMACEUTICALS HOLDING CORP (TNXP)
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
